Abstract
Indwelling pleural catheters (IPC) have become the main stay for patient centred treatment of malignant pleural effusions. They can be inserted as day case procedures, have very low complication rates and improve quality of life. They also reduce inpatient length of stay in respect to the malignant effusion. We have an established pleural service and analysed our practice over 4 years. All the notes of patients requiring IPC insertion between 2015 and 2019 were reviewed. 159 patients had an IPC inserted. 130 had died; mean survival 162 days. Mean age was 72.3 years and 39% of patients were female (n=62). 78 IPCs were done for mesothelioma, 61 done for other malignancies (29 lung, 24 breast, rest varied : melanoma, prostate cancer, ovarian cancer, colorectal cancers amongst others). 20 were done for non-malignant indications such as fibrinous pleuritis, cardiac amyloidosis, effusions of unknown cause, liver cirrhosis, heart failure. 146 IPCs were inserted as a day case, the rest were already inpatients. IPCs are done in theatre with a one off dose of prophylactic antibiotics. Complications included 4 infections (3 of pleural space by staph epidermidis and gram negative bacilli, 1 of site: site infection by staph. aureus {MSSA} – 2.5% (lower than national average in the UK), 6 blockages- 3.8 %, requiring removal (less than national average) and 2 small pneumothoraces post insertion. 1 patient had fast AF and hypotension post insertion.13 patients had loculations requiring intervention (8%- lower than national average) with intra-fibrinolytics, All of these patients had died by the time of data collection and we have stopped this practice in light of recent evidence that palliative care is more apporpriate. 57 IPCs were removed (36%- at a national average) for spontaneous pleurodesis. We provide an safe and effective indwelling pleural catheter service. Our lower rates of infection might be due to prophylactic antibiotic usage and insertion in theatre.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
More From: Journal of Thoracic Oncology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.